Neurocrine Biosciences Inc
NASDAQ:NBIX

Watchlist Manager
Neurocrine Biosciences Inc Logo
Neurocrine Biosciences Inc
NASDAQ:NBIX
Watchlist
Price: 142.29 USD 0.27% Market Closed
Updated: May 18, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

3.5B
+7%
Assets
Growth Rates:
1 Year
+47%
3 Years
+88%
5 Years
+263%
7 Years
+1 100%
10 Years
+1 143%
1.1B
+7%
Liabilities
Growth Rates:
1 Year
+61%
3 Years
+70%
5 Years
+98%
7 Years
+2 474%
10 Years
+3 274%
2.4B
+7%
Equity
Growth Rates:
1 Year
+42%
3 Years
+98%
5 Years
+483%
7 Years
+866%
10 Years
+866%

Balance Sheet Decomposition
Neurocrine Biosciences Inc

3.5B
Assets
1.1B
Liabilities
3.5B
Assets
1.1B
Liabilities
Current Assets 1.8B
Cash & Short-Term Investments 1.2B
Receivables 450.7m
Other Current Assets 137.7m
Non-Current Assets 1.7B
Long-Term Investments 863.9m
PP&E 346.1m
Intangibles 34.3m
Other Non-Current Assets 429.1m
Current Liabilities 712.9m
Accounts Payable 308.5m
Accrued Liabilities 118.9m
Other Current Liabilities 285.5m
Non-Current Liabilities 373.4m
Other Non-Current Liabilities 373.4m

Balance Sheet
Neurocrine Biosciences Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
31
74
83
255
142
112
187
341
263
1 032
Cash Equivalents
31
74
83
255
142
112
187
341
263
1 032
Short-Term Investments
163
305
224
261
509
558
614
371
726
781
Total Receivables
0
0
0
31
57
127
157
186
350
439
Accounts Receivables
0
0
0
31
57
127
157
186
350
439
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
11
17
28
31
35
38
Other Current Assets
4
5
3
8
19
17
30
46
79
98
Total Current Assets
198
384
310
555
738
831
1 016
973
1 454
1 607
PP&E Net
3
3
6
11
34
116
127
156
146
347
PP&E Gross
3
3
6
11
34
116
127
156
146
347
Accumulated Depreciation
29
27
26
28
28
34
42
52
66
83
Intangible Assets
0
0
0
0
0
0
0
0
37
36
Long-Term Investments
38
83
44
247
216
356
265
624
402
849
Other Long-Term Assets
5
5
5
5
6
3
326
320
331
412
Total Assets
243
N/A
475
+95%
365
-23%
818
+124%
993
+21%
1 306
+31%
1 735
+33%
2 073
+19%
2 369
+14%
3 251
+37%
Liabilities
Accounts Payable
0
3
5
6
38
46
98
143
236
318
Accrued Liabilities
12
19
21
48
34
73
81
100
129
163
Short-Term Debt
0
0
0
0
0
409
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
169
170
Other Current Liabilities
4
4
4
1
15
38
8
4
3
4
Total Current Liabilities
16
26
30
54
88
565
187
246
538
655
Long-Term Debt
0
0
0
370
389
0
318
335
0
0
Other Liabilities
19
25
20
21
36
104
104
118
123
365
Total Liabilities
34
N/A
50
+47%
50
0%
446
+787%
512
+15%
669
+31%
609
-9%
699
+15%
661
-5%
1 019
+54%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
826
915
1 056
1 199
1 178
1 133
725
636
407
157
Additional Paid In Capital
1 035
1 341
1 371
1 573
1 660
1 768
1 850
2 011
2 122
2 382
Other Equity
0
1
0
2
2
1
2
2
8
7
Total Equity
209
N/A
425
+103%
315
-26%
372
+18%
481
+29%
637
+32%
1 126
+77%
1 374
+22%
1 708
+24%
2 232
+31%
Total Liabilities & Equity
243
N/A
475
+95%
365
-23%
818
+124%
993
+21%
1 306
+31%
1 735
+33%
2 073
+19%
2 369
+14%
3 251
+37%
Shares Outstanding
Common Shares Outstanding
77
86
87
89
91
92
94
95
97
99

See Also

Summary
NBIX intrinsic value, competitors valuation, and company profile.
DCF Valuation
NBIX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NBIX stock valuation using valuation multiples.
Wall Street Estimates
NBIX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NBIX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.